Abstract
Ecotoxicity data is still scarce for most pharmaceuticals. The vast knowledge base derived from mammalian studies during drug development could, however, provide insights into possible effects of residual pharmaceuticals in exposed nontarget species. In this chapter, we start from a theoretical point-of-view and discuss ways to predict the conservation of proteins and pathways known to be affected by drugs in model species and in the human body. We also describe different databases where relevant pharmacological data is easily accessible and what type of data is suitable for large-scale comparisons. We believe high-throughput comparative efforts can aid in the prioritization of which drugs need further assessment of their environmental risks, assist in the selection of appropriate test organisms and endpoints and identify limitations with species extrapolations. Without any attempt to be comprehensive, we also give some selected examples on both theoretically and empirically derived pharmacokinetics and pharmacodynamic data in nontarget species.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Garric J, Vollat B, Duis K, Pery A, Junker T, Ramil M, Fink G, Ternes TA (2007) Effects of the parasiticide ivermectin on the cladoceran Daphnia magna and the green alga Pseudokirchneriella subcapitata. Chemosphere 69:903–910
Kidd KA, Blanchfield PJ, Mills KH, Palace VP, Evans RE, Lazorchak JM, Flick RW (2007) Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci U S A 104:8897–8901
Zeilinger J, Steger-Hartmann T, Maser E, Goller S, Vonk R, Lange R (2009) Effects of synthetic gestagens on fish reproduction. Environ Toxicol Chem 28:2663–2670
Winter MJ, Owen SF, Murray-Smith RM, Panter GH, Hetheridge MJ, Kinter LB (2009) Using data from drug discovery and development to aid the aquatic environmental risk assessment of human pharmaceuticals: concepts, considerations and challenges. Integr Environ Assess Manag 6:38–51
Ankley GT, Brooks BW, Huggett DB, Sumpter JP (2007) Repeating history: pharmaceuticals in the environment. Environ Sci Technol 41:8211–8217
Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DGJ (2008) Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 42:5807–5813
Kostich MS, Lazorchak JM (2008) Risks to aquatic organisms posed by human pharmaceutical use. Sci Total Environ 389:329–339
Breitholtz M, Bengtsson BE (2001) Oestrogens have no hormonal effect on the development and reproduction of the harpacticoid copepod Nitocra spinipes. Mar Pollut Bull 42:879–886
ECETOC (2007) Intelligent testing strategies in ecotoxicology: mode-of action approach for specifically acting chemicals. ECETOC Technical Report No.102. http://www.ecetoc.org/index.php?mact=MCSoap,cntnt01,details,0&cntnt01by_category=16&cntnt01template=display_list_science&cntnt01document_id=281&cntnt01returnid=101. Accessed Sept 2008
Kreke N, Dietrich DR (2008) Physiological endpoints for potential SSRI interactions in fish. Crit Rev Toxicol 38:215–247
Owen SF, Giltrow E, Huggett DB, Hutchinson TH, Saye J, Winter MJ, Sumpter JP (2007) Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish. Aquat Toxicol 82:145–162
Brain RA, Hanson ML, Solomon KR, Brooks BW (2008) Aquatic plants exposed to pharmaceuticals: effects and risks. Rev Environ Contam Toxicol 192:67–115
EMEA (2006) Guideline on the environmental Risk Assessment of Medical Products for Human Use. The Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency, CHMP/SWP/4447/00. http://www.tga.gov.au/docs/pdf/euguide/swp/444700en.pdf. Accessed Sept 2009
FDA (1998) Guidance for environmental assessment of human drug and biologics applications. Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. http://www.fda.gov/cder/guidance/1730fnl.pdf. Accessed Sept 2009
Maack G, Adler N, Bachmann J, Ebert I, Hickmann S, Küster A, B. R (2010) Environmental risk assessment of medicinal products for human use: does the risk assessment reflect the reality? SETAC Europe: 20th annual meeting.http://www.eventure-online.com/eventure/publicAbstractView.do;jsessionid=abcrY0Urm3inMfjVSloOs?id=115911&congressId=3358. Accessed June 2010
Holbrook JD, Sanseau P (2007) Drug discovery and computational evolutionary analysis. Drug Discov Today 12:826–832
Bork P, Dandekar T, Diaz-Lazcoz Y, Eisenhaber F, Huynen M, Yuan Y (1998) Predicting function: from genes to genomes and back. J Mol Biol 283:707–725
Li L, Stoeckert CJ Jr, Roos DS (2003) OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res 13:2178–2189
Chen F, Mackey AJ, Vermunt JK, Roos DS (2007) Assessing performance of orthology detection strategies applied to eukaryotic genomes. PLoS One 2:e383
Dolinski K, Botstein D (2007) Orthology and functional conservation in eukaryotes. Annu Rev Genet 41:465–507
Felsenstein J (1988) Phylogenies from molecular sequences: inference and reliability. Annu Rev Genet 22:521–565
Altenhoff AM, Dessimoz C (2009) Phylogenetic and functional assessment of orthologs inference projects and methods. PLoS Comput Biol 5:e1000262
Gabaldon T (2008) Large-scale assignment of orthology: back to phylogenetics? Genome Biol 9:235
Vilella AJ, Severin J, Ureta-Vidal A, Heng L, Durbin R, Birney E (2009) EnsemblCompara GeneTrees: complete, duplication-aware phylogenetic trees in vertebrates. Genome Res 19:327–335
Dehal PS, Boore JL (2006) A phylogenomic gene cluster resource: the Phylogenetically Inferred Groups (PhIGs) database. BMC Bioinformatics 7:201
Pearson W (2004) Finding protein and nucleotide similarities with FASTA. Curr Protoc Bioinformatics Chapter 3:Unit3.9
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402
Ding G, Sun Y, Li H, Wang Z, Fan H, Wang C, Yang D, Li Y (2008) EPGD: a comprehensive web resource for integrating and displaying eukaryotic paralog/paralogon information. Nucleic Acids Res 36:D255–D262
Tatusov RL, Koonin EV, Lipman DJ (1997) A genomic perspective on protein families. Science 278:631–637
Raymond J, Zhaxybayeva O, Gogarten JP, Gerdes SY, Blankenship RE (2002) Whole-genome analysis of photosynthetic prokaryotes. Science 298:1616–1620
Remm M, Storm CE, Sonnhammer EL (2001) Automatic clustering of orthologs and in-paralogs from pairwise species comparisons. J Mol Biol 314:1041–1052
van Dongen S (2000) Graph clustering by flow simulation. PhD thesis, University of Utrecht, Utrecht
Enright AJ, Van Dongen S, Ouzounis CA (2002) An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res 30:1575–1584
Randall DJ, Connell DW, Yang R, Wu SS (1998) Concentrations of persistent lipophilic compounds in fish are determined by exchange across the gills, not through the food chain. Chemosphere 37:1263–1270
Barnes RSK, Calow P, Olive PJW, Golding DW, Spicer JI (2001) The invertebrates—a synthesis. Blackwell Science, Malden
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–25
Huggett BD, Cook CJ, Ericson FJ, Williams RT (2003) A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum Ecol Risk Assess 9:1789–1799
Brown JN, Paxeus N, Forlin L, Larsson DGJ (2007) Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ Toxicol Pharmacol 24:267–274
Owen SF, Huggett DB, Hutchinson TH, Hetheridge MJ, Kinter LB, Ericson JF, Sumpter JP (2009) Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry. Aquat Toxicol 93:217–224
Fick J, Lindberg RH, Parkkonen J, Arvidsson B, Tysklind M, Larsson DGJ (2010) Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environ Sci Technol 44:2661–2666
Fick J, Lindberg RH, Tysklind M, Larsson DGJ (2010) Predicted critical environmental concentrations for 500 pharmaceuticals. Regul Toxicol Pharmacol 58(3):516–523
Roos V, Gunnarsson L, Fick J, Larsson DGJ, Ruden C (2012) Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection. Science of the Total Environment 421–422:102–110
Rendal C, Kusk KO, Trapp S (2011) The effect of pH on the uptake and toxicity of the bivalent weak base chloroquine tested on Salix viminalis and Daphnia magna. Environ Toxicol Chem 30:354–359
Valenti TW, Perez-Hurtado P, Chambliss KC, Brooks BW (2009) Aquatic toxicity of sertraline to Pimephales promelas at environmentally relevant surface water pH. Environ Toxicol Chem 28:2685–94
Dobson PD, Kell DB (2008) Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov 7:205–220
Benet LZ, Kroetz DL, Sheiner LB (1996) Pharmacokinetics. The dynamics of drug absorption distribution and elimination. McGraw Hill, New York.
Kratochwil NA, Huber W, Muller F, Kansy M, Gerber PR (2002) Predicting plasma protein binding of drugs: a new approach. Biochem Pharmacol 64:1355–1374
Gray JE, Doolittle RF (1992) Characterization, primary structure, and evolution of lamprey plasma albumin. Protein Sci 1:289–302
Kleinow KM, Nichols JW, Hayton WL, Mckim JM, Barron MG (2008) The toxicokinetics in fish. In: Di Gulio RT, Hinton DE (eds) The toxicology of fishes. CRC Press, Boca Raton
Bobe J, Guiguen Y, Fostier A (2010) Diversity and biological significance of sex hormone-binding globulin in fish, an evolutionary perspective. Mol Cell Endocrinol 316:66–78
Solange M-Q, Geoffrey LH (2008) Sex Hormone-Binding Globulin in Fish Gills is a Portal for Sex Steroids Breached by Xenobiotics. Endocrinology 149:4269–4275
Miguel-Queralt S, Hammond GL (2008) Sex hormone-binding globulin in fish gills is a portal for sex steroids breached by xenobiotics. Endocrinology 149:4269–4275
Iyanagi T (2007) Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification. Int Rev Cytol 260:35–112
Werck-Reichhart D, Feyereisen R (2000) Cytochromes P450: a success story. Genome Biol 1(6):reviews3003
Graham MJ, Lake BG (2008) Induction of drug metabolism: species differences and toxicological relevance. Toxicology 254:184–191
Yang X, Zhang B, Molony C, Chudin E, Hao K, Zhu J, Gaedigk A, Suver C, Zhong H, Leeder JS et al (2010) Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res. doi:10.1101/gr.103341.109
Nebert DW, Gonzalez FJ (1987) P450 genes: structure, evolution, and regulation. Annu Rev Biochem 56:945–993
Schlenk D, Celander M, Gallagher EP, George S, James M, Kullman SW, van den Hurk P, Willett K (2008) Biotransformation in Fishes. In: Hinton DE (ed) Di Giulio DR. The Toxicology of Fishes CRC Press, Boca Raton (FL)
Fink-Gremmels J (2008) Implications of hepatic cytochrome P450-related biotransformation processes in veterinary sciences. Eur J Pharmacol 585:502–509
Prasad JC, Goldstone JV, Camacho CJ, Vajda S, Stegeman JJ (2007) Ensemble modeling of substrate binding to cytochromes P450: analysis of catalytic differences between CYP1A orthologs. Biochemistry 46:2640–2654
Mattingly CJ, Toscano WA (2001) Posttranscriptional silencing of cytochrome P4501A1 (CYP1A1) during zebrafish (Danio rerio) development. Dev Dyn 222:645–654
Lee MD, Ayanoglu E, Gong L (2006) Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions. Xenobiotica 36:1013–1080
Hegelund T, Ottosson K, Radinger M, Tomberg P, Celander MC (2004) Effects of the antifungal imidazole ketoconazole on CYP1A and CYP3A in rainbow trout and killifish. Environ Toxicol Chem 23:1326–1334
Blanchard RL, Freimuth RR, Buck J, Weinshilboum RM, Coughtrie MW (2004) A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 14:199–211
Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677–685
Blanchette B, Feng X, Singh BR (2007) Marine glutathione S-transferases. Mar Biotechnol (NY) 9:513–542
Rattner BA, Whitehead MA, Gasper G, Meteyer C, Link WA, Taggart MA, Meharg AA, Pattee OH, Pain DJ (2008) Apparent tolerance of turkey vultures (Cathartes aura) to the non-steroidal anti-inflammatory drug Diclofenac. Environ Toxicol Chem 27(11):2341–5
van de Waterbeemd H, Gifford E (2003) ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2:192–204
Mohan CG, Gandhi T, Garg D, Shinde R (2007) Computer-assisted methods in chemical toxicity prediction. Mini Rev Med Chem 7:499–507
Chang C, Duignan DB, Johnson KD, Lee PH, Cowan GS, Gifford EM, Stankovic CJ, Lepsy CS, Stoner CL (2008) The development and validation of a computational model to predict rat liver microsomal clearance. J Pharm Sci 98(8):2857–67
Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34:D668–D672
Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36:D901–D906
Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993–996
Sakharkar MK, Sakharkar KR, Pervaiz S (2007) Druggability of human disease genes. Int J Biochem Cell Biol 39:1156–1164
Bauer RA, Gunther S, Jansen D, Heeger C, Thaben PF, Preissner R (2009) SuperSite: dictionary of metabolite and drug binding sites in proteins. Nucleic Acids Res 37:D195–D200
Gong L, Owen RP, Gor W, Altman RB, Klein TE (2008) PharmGKB: an integrated resource of pharmacogenomic data and knowledge. Curr Protoc Bioinformatics Chapter 14:Unit14 17
Frolkis A, Knox C, Lim E, Jewison T, Law V, Hau DD, Liu P, Gautam B, Ly S, Guo AC et al (2010) SMPDB: the Small Molecule Pathway Database. Nucleic Acids Res 38:D480–D487
Garcia-Reyero N, Adelman I, Liu L, Denslow N (2008) Gene expression profiles of fathead minnows exposed to surface waters above and below a sewage treatment plant in Minnesota. Mar Environ Res 66:134–136
Kristiansson E, Asker N, Forlin L, Larsson DGJ (2009) Characterization of the Zoarces viviparus liver transcriptome using massively parallel pyrosequencing. BMC Genomics 10:345
Woo Y, Affourtit J, Daigle S, Viale A, Johnson K, Naggert J, Churchill G (2004) A comparison of cDNA, oligonucleotide, and Affymetrix GeneChip gene expression microarray platforms. J Biomol Tech 15:276–284
Kristiansson E, Sjogren A, Rudemo M, Nerman O (2005) Weighted analysis of paired microarray experiments. Stat Appl Genet Mol Biol 4:Article30
Kuo WP, Liu F, Trimarchi J, Punzo C, Lombardi M, Sarang J, Whipple ME, Maysuria M, Serikawa K, Lee SY et al (2006) A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies. Nat Biotechnol 24:832–840
Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY et al (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24:1151–1161
t Hoen PA, Ariyurek Y, Thygesen HH, Vreugdenhil E, Vossen RH, de Menezes RX, Boer JM, van Ommen GJ, den Dunnen JT (2008) Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res 36:141
Heckmann LH, Sibly RM, Connon R, Hooper HL, Hutchinson TH, Maund SJ, Hill CJ, Bouetard A, Callaghan A (2008) Systems biology meets stress ecology: linking molecular and organismal stress responses in Daphnia magna. Genome Biol 9:R40
Curtis RK, Oresic M, Vidal-Puig A (2005) Pathways to the analysis of microarray data. Trends Biotechnol 23:429–435
Salomonis N, Hanspers K, Zambon AC, Vranizan K, Lawlor SC, Dahlquist KD, Doniger SW, Stuart J, Conklin BR, Pico AR (2007) GenMAPP 2: new features and resources for pathway analysis. BMC Bioinformatics 8:217
Pandey R, Guru RK, Mount DW (2004) Pathway Miner: extracting gene association networks from molecular pathways for predicting the biological significance of gene expression microarray data. Bioinformatics 20:2156–2158
Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, de Bono B, Garapati P, Hemish J, Hermjakob H, Jassal B et al (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 37:D619–D622
Thornton JW, Need E, Crews D (2003) Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science 301:1714–1717
Gunnarsson L, Kristiansson E, Forlin L, Nerman O, Larsson DG (2007) Sensitive and robust gene expression changes in fish exposed to estrogen—a microarray approach. BMC Genomics 8:149
Kristiansson E, Thorsen M, Tamas MJ, Nerman O (2009) Evolutionary forces act on promoter length: identification of enriched cis-regulatory elements. Mol Biol Evol 26:1299–1307
Schmid CD, Perier R, Praz V, Bucher P (2006) EPD in its twentieth year: towards complete promoter coverage of selected model organisms. Nucleic Acids Res 34:D82–D85
Acknowledgments
The authors wish to thank the two anonymous reviewers for valuable comments and the Foundation for Strategic Environmental Research (MISTRA) and the Swedish Research Council (VR) for financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Gunnarsson, L., Kristiansson, E., Larsson, D.G.J. (2012). Environmental Comparative Pharmacology: Theory and Application. In: Brooks, B., Huggett, D. (eds) Human Pharmaceuticals in the Environment. Emerging Topics in Ecotoxicology, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3473-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3473-3_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3419-1
Online ISBN: 978-1-4614-3473-3
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)